![Markus Haeberlein](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Markus Haeberlein
Direktör/Styrelseledamot på
XSPRAY PHARMA AB
Profil
Markus Haeberlein is currently an Independent Director at Xspray Pharma AB since 2025 and Executive Vice President-Discovery Science at Parabilis Medicines, Inc. since 2024.
Former positions include Director & Head-Medicinal Chemistry at AstraZeneca LP, Senior Vice President-Research at Alkermes Plc, and Senior Vice President & Head-Research at Proteostasis Therapeutics, Inc. from 2012 to 2014.
Education includes graduate and doctorate degrees from the Royal Institute of Technology.
Aktiva positioner av Markus Haeberlein
| Företag | Position | Start |
|---|---|---|
| XSPRAY PHARMA AB | Direktör/Styrelseledamot | 2025-01-01 |
| PARABILIS MEDICINES, INC. | Företagsledare/Principal | 2024-03-01 |
Tidigare kända positioner av Markus Haeberlein
| Företag | Position | Slut |
|---|---|---|
AstraZeneca LP
 AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE. | Direktör/Styrelseledamot | - |
| ALKERMES PLC | Teknisk/Vetenskaplig/F&U Direktör | - |
| PROTEOSTASIS THERAPEUTICS, INC. | Teknisk/Vetenskaplig/F&U Direktör | - |
Markus Haeberleins utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
38
Första gradens relationer
6
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 6 |
|---|---|
Royal Institute of Technology
 Royal Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Proteostasis Therapeutics, Inc.
 Proteostasis Therapeutics, Inc. BiotechnologyHealth Technology Develops disease-modifying therapeutics for orphan and neurodegenerative diseases | Health Technology |
Xspray Pharma AB
 Xspray Pharma AB Pharmaceuticals: MajorHealth Technology Develops and produces particulate materials for the pharmaceutical industry | Health Technology |
AstraZeneca LP
AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE. | Health Technology |
Alkermes Plc
 Alkermes Plc Pharmaceuticals: MajorHealth Technology Manufactures and commercializes pharmaceutical products to treat neurodegenerative disorders and cancer | Health Technology |
Parabilis Medicines
 Parabilis Medicines Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops medicines for cancers and tumors | Health Technology |
